TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Importantly, NTX restored TRPM3 in NK cells from both post-COVID-19 condition and ME/CFS groups, suggesting TRPM3 dysfunction overlap in the pathomechanism of both conditions.